Clinical Trials Browser

Phase 1 × NIH × Sunitinib × Clear all

NCT05687123 2026-03-19

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Phase 1 Recruiting

Gastrointestinal

Adenoma, Islet Cell, Pancreatic Neoplasms

NCT00813423 2023-08-02

Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy

Phase 1 Completed

Adult Solid Neoplasm

NCT00499135 2017-10-10

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Phase 1 Completed

Carcinoma, Renal Cell

NCT01243359 2014-04-02

Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies

Phase 1 Completed

Carcinoma, Renal Cell

NCT00357318 2014-02-24

Bevacizumab and Sunitinib in Treating Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00462553 2014-02-24

Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00387920 2014-01-28

Sunitinib in Treating Young Patients With Refractory Solid Tumors

Phase 1 Completed

CNSOther solid neoplasm

Central Nervous System Metastases

NCT00906360 2013-07-02

Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Phase 1 Terminated

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms